Neuromuscular Blockade: Difference between revisions
Jump to navigation
Jump to search
No edit summary Tags: Mobile edit Mobile web edit |
No edit summary |
||
Line 10: | Line 10: | ||
__NOTOC__ __NOEDITSECTION__ | __NOTOC__ __NOEDITSECTION__ | ||
https://pubmed.ncbi.nlm.nih.gov/31584918/ | [https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | ||
https://pubmed.ncbi.nlm.nih.gov/10983014/ | [https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children] | ||
[[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium | [[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium | ||
[https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube] |
Revision as of 22:33, 11 September 2021
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Neuromuscular blockade in children
Test Your Knowledge: unique advantage of rocuronium